Format

Send to

Choose Destination
See comment in PubMed Commons below
Magn Reson Imaging Clin N Am. 2009 Feb;17(1):159-67. doi: 10.1016/j.mric.2009.01.003.

Nephrogenic systemic fibrosis.

Author information

1
Department of Diagnostic Radiology, Yale University School of Medicine, 333 Cedar Street, P.O. Box 208042, New Haven, CT 06520-5913, USA. jeffrey.weinreb@yale.edu

Abstract

There seems to be an association between exposure to intravenous gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF), a debilitating and sometimes fatal disease. This article addresses the relationship between GBCAs and NSF and answers some common questions. The policy deployed at Yale-New Haven Hospital for prevention of NSF and screening for patients at risk is delineated and discussed along with recommendations by the Food and Drug Administration.

PMID:
19364606
DOI:
10.1016/j.mric.2009.01.003
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center